CMOs Thrive on New Trend: Pharma Personnel Shortages

/by Bruce Carlson

Biotechnology BCMO services, including both clinical and commercial production, were estimated at $11.9 billion in 2021. This according to the just-published Kalorama market analysis of the BCMO market. – https://kaloramainformation.com/product/biopharmaceutical-contract-manufacturing-organization-cmo-market-2022/ This segment has been expanding strongly by an estimated 13% per year since 2016, with increased growth of 15.5% per year from 2021 to 2026. […]

Read more

American College of Physicians Discourages DTC Genetic Testing

/by Bruce Carlson

A recent article in the ACP journal discourages the use of DTC genetic testing and recommends that testing be undertaken in the context of a patient-physician relationship with appropriate counseling. Physicians, healthcare systems, and others with access to patient data must safeguard the privacy, confidentiality, and security of patient information, including genomic information, ACP noted. […]

Read more

What You May Have Missed at AACC 2022: Free White Paper

/by Bruce Carlson

From a biosensor that won AACC’s disruptive technology award, to a new use for AI in IVD, to the realities of automation at real-world laboratories, this year’s AACC conference had a lot to offer. Many Kalorama customers either were not able to make the show or were at the show but may have missed a […]

Read more

IVD in India: Growing, Aging Population Impacts Healthcare

/by Daniel Granderson

India, which is expected to surpass China as the most populous country in the world by 2023, has a growing $1,482 million ($1.5 billion) in vitro diagnostics (IVD) industry that is forecast to increase through 2026, as reported by Kalorama Information in the new medical market research study, In Vitro Diagnostics (IVD) in India. The […]

Read more

Perkin Elmer Splits Analytical and IVD/Life Science Companies

/by Bruce Carlson

Perkin Elmer announced it has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital, a leading growth-oriented private equity firm, for total consideration of $2.45 billion in cash, $2.30 billion of which will be received at the closing and $150 million of which will […]

Read more

What We Are Looking Forward to at AACC 2022

/by Bruce Carlson

As the laboratory and IVD industry gears up for what’s expected to be the largest in-person meeting since the COVID-19 pandemic, our editors and analysts will be in Chicago and on the scene.  We see several issues on the horizon that we’ll be curious to see how laboratorians and IVD industry leaders address.  Lab labor […]

Read more

In Vitro Diagnostics Business Outlook: Blood Typing Has Rebounded

/by Bruce Carlson

In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. The overall market is expected to stabilize in 2022 and grow at a 1% […]

Read more

COVID-19 Test Market: $33BN in Revenues in 2021, Future Still a Guess

/by Bruce Carlson

Kalorama has just completed a report on the COVID-19 in vitro diagnostic testing market.  2021 was a year in which point-of-care antigen tests, lab-based PCR tests, rapid PCR and even home tests were available to the market.  Also antibody tests, NGS tests and other tests were brought to bear in diagnosing cases. The scourge of […]

Read more

Infectious Disease Testing Expected to Grow Beyond COVID-19

/by Bruce Carlson

While COVID-19 has made the need for  in vitro diagnostics (IVD) that can detect infectious diseases front and center, demand for these tests was building before the pandemic and revenues for test products will grow says a report from a major publisher of IVD market research.    The industry consists of tests and related products […]

Read more

Molecular Point of Care Market Reaches 3.5 Billion

/by Bruce Carlson

The molecular point of care market reached 3,555 million in 2021, according to Kalorama Information’s latest report. The Market and Potential for Molecular Point-of-Care. COVID-19 sales were the main driver. That is 10x growth in revenues from 2019.  The COVID-19 pandemic and consistent arrival of variants are the determining factor, and the continued presence of […]

Read more